These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 19492866

  • 1. The central region of BRCA1 binds preferentially to supercoiled DNA.
    Brázda V, Jagelska EB, Liao JC, Arrowsmith CH.
    J Biomol Struct Dyn; 2009 Aug; 27(1):97-104. PubMed ID: 19492866
    [Abstract] [Full Text] [Related]

  • 2. Tumor suppressor protein p53 binds preferentially to supercoiled DNA.
    Palecek E, Vlk D, Stanková V, Brázda V, Vojtesek B, Hupp TR, Schaper A, Jovin TM.
    Oncogene; 1997 Oct; 15(18):2201-9. PubMed ID: 9393978
    [Abstract] [Full Text] [Related]

  • 3. Preferential binding of IFI16 protein to cruciform structure and superhelical DNA.
    Brázda V, Coufal J, Liao JC, Arrowsmith CH.
    Biochem Biophys Res Commun; 2012 Jun 15; 422(4):716-20. PubMed ID: 22618232
    [Abstract] [Full Text] [Related]

  • 4. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?
    Mark WY, Liao JC, Lu Y, Ayed A, Laister R, Szymczyna B, Chakrabartty A, Arrowsmith CH.
    J Mol Biol; 2005 Jan 14; 345(2):275-87. PubMed ID: 15571721
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments.
    Palecek E, Brázdová M, Cernocká H, Vlk D, Brázda V, Vojtesek B.
    Oncogene; 1999 Jun 17; 18(24):3617-25. PubMed ID: 10380883
    [Abstract] [Full Text] [Related]

  • 7. Mapping and conformational characterization of the DNA-binding region of the breast cancer susceptibility protein BRCA1.
    Naseem R, Sturdy A, Finch D, Jowitt T, Webb M.
    Biochem J; 2006 May 01; 395(3):529-35. PubMed ID: 16460311
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.
    Campbell SJ, Edwards RA, Glover JN.
    Structure; 2010 Feb 10; 18(2):167-76. PubMed ID: 20159462
    [Abstract] [Full Text] [Related]

  • 10. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
    Pyrpassopoulos S, Ladopoulou A, Vlassi M, Papanikolau Y, Vorgias CE, Yannoukakos D, Nounesis G.
    Biophys Chem; 2005 Apr 01; 114(1):1-12. PubMed ID: 15792855
    [Abstract] [Full Text] [Related]

  • 11. The BRCT domain is a phospho-protein binding domain.
    Yu X, Chini CC, He M, Mer G, Chen J.
    Science; 2003 Oct 24; 302(5645):639-42. PubMed ID: 14576433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective binding of tumor suppressor p53 protein to topologically constrained DNA: Modulation by intercalative drugs.
    Pivonková H, Sebest P, Pecinka P, Tichá O, Nemcová K, Brázdová M, Jagelská EB, Brázda V, Fojta M.
    Biochem Biophys Res Commun; 2010 Mar 19; 393(4):894-9. PubMed ID: 20175992
    [Abstract] [Full Text] [Related]

  • 14. Roles of BRCA1 and its interacting proteins.
    Deng CX, Brodie SG.
    Bioessays; 2000 Aug 19; 22(8):728-37. PubMed ID: 10918303
    [Abstract] [Full Text] [Related]

  • 15. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW, Henderson BR.
    Cell Signal; 2007 Sep 19; 19(9):1879-92. PubMed ID: 17531442
    [Abstract] [Full Text] [Related]

  • 16. Cancer predisposing mutations in BRCT domains.
    di Masi A, Gullotta F, Cappadonna V, Leboffe L, Ascenzi P.
    IUBMB Life; 2011 Jul 19; 63(7):503-12. PubMed ID: 21698754
    [Abstract] [Full Text] [Related]

  • 17. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA, Manke IA, Lowery DM, Ho T, Haire LF, Yaffe MB, Smerdon SJ.
    Nat Struct Mol Biol; 2004 Jun 19; 11(6):512-8. PubMed ID: 15133502
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human 170 kDa and 180 kDa topoisomerases II bind preferentially to curved and left-handed linear DNA.
    Bechert T, Diekmann S, Arndt-Jovin DJ.
    J Biomol Struct Dyn; 1994 Dec 19; 12(3):605-23. PubMed ID: 7727061
    [Abstract] [Full Text] [Related]

  • 20. [BRCA1 and genomic stability].
    Fan WH, Zhan QM.
    Ai Zheng; 2003 Mar 19; 22(3):331-5. PubMed ID: 12654199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.